VYNE Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYNE and other ETFs, options, and stocks.About VYNE
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology.
CEODavid Domzalski
CEODavid Domzalski
Employees13
Employees13
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded2011
Founded2011
Employees13
Employees13
VYNE Key Statistics
Market cap11.94M
Market cap11.94M
Price-Earnings ratio-0.46
Price-Earnings ratio-0.46
Dividend yield—
Dividend yield—
Average volume850.31K
Average volume850.31K
High today$0.3686
High today$0.3686
Low today$0.353
Low today$0.353
Open price$0.353
Open price$0.353
Volume335.45K
Volume335.45K
52 Week high$4.30
52 Week high$4.30
52 Week low$0.2805
52 Week low$0.2805
Stock Snapshot
With a market cap of 11.94M, VYNE Therapeutics(VYNE) trades at $0.36. The stock has a price-to-earnings ratio of -0.46.
As of 2025-12-16, VYNE Therapeutics(VYNE) stock has fluctuated between $0.35 and $0.37. The current price stands at $0.36, placing the stock +1.6% above today's low and -2.7% off the high.
VYNE Therapeutics(VYNE) shares are trading with a volume of 335.45K, against a daily average of 850.31K.
During the past year, VYNE Therapeutics(VYNE) stock moved between $0.28 at its lowest and $4.30 at its peak.
During the past year, VYNE Therapeutics(VYNE) stock moved between $0.28 at its lowest and $4.30 at its peak.
People also own
Based on the portfolios of people who own VYNE. This list is generated using Robinhood data, and it’s not a recommendation.